Contact Us Today!

 

Request a no-obligation, custom revenue projection for your practice:

  • Secure SSL encrypted form submission

Frequently Asked Questions

How does the TM Flow device enhance patient care for older adults and those with a history of smoking or circulation problems?2024-06-26T20:24:37+00:00

For older adults and individuals with a history of smoking or circulation problems, the TM Flow device is particularly beneficial. It performs the ankle-brachial index (ABI) test, which is recommended by the American Heart Association for adults aged 50+ with such histories and all adults over 70 years old. This test helps in the early detection of peripheral artery disease (PAD), enabling timely management and treatment. The TM Flow device’s comprehensive assessments ensure that patients receive accurate diagnoses and appropriate care, improving overall health outcome.

What are the benefits of using the TM Flow device in a medical practice?2024-06-26T20:24:23+00:00

The TM Flow device offers numerous benefits for medical practices, including non-invasive and accurate testing, early detection of autonomic and arterial dysfunctions, and comprehensive diagnostics that reduce the overall cost of patient care. Additionally, the device’s tests are easy to bill with multi-code diagnostics, making it a valuable investment for enhancing patient care and optimizing practice efficiency. It also supports compliance with standards of care recommended by leading health organizations.

Is the TM Flow device covered by insurance?2024-06-26T20:24:12+00:00

Yes, the TM Flow device is covered by Medicare and most private pay carriers. Specific CPT codes, such as 95921 for cardiovagal innervation and 93923 for ankle-brachial pressure index, ensure that the diagnostics are easy to bill. Coverage and reimbursements may vary depending on the Medicare locality, but the comprehensive diagnostics offered by the TM Flow device are widely recognized and supported by insurance providers.

Why is autonomic nervous system testing important for diabetes and cardiovascular patients?2024-06-26T20:23:56+00:00

Autonomic nervous system testing is crucial for diabetes and cardiovascular patients because it helps in the early detection of autonomic neuropathy, which is a common complication in these conditions. Early detection through ANS testing allows for timely intervention and management, reducing the risk of further complications. The American Diabetes Association recommends ANS testing as a standard of care for patients with Type 1 and Type 2 diabetes, highlighting its importance in effective diabetes management.

What is the TM Flow device and how does it work?2024-06-26T20:23:37+00:00

The TM Flow device is an advanced, non-invasive diagnostic tool designed to perform a series of tests that aid in the identification and early detection of autonomic nervous system (ANS) and arterial dysfunctions. It provides quantitative assessments of the ANS, helping to distinguish between early and late stages of autonomic neuropathy. The TM Flow device is particularly valuable for cardiovascular and diabetic autonomic neuropathy (DAN) testing, making it an essential tool in diabetes management and cardiovascular assessments.

Enhancing Patient Care: The Role of ANS Testing in Diabetes Management

 

Understanding the Importance of Early Detection and Intervention

 

Diabetes management poses significant challenges for healthcare providers due to the potential for long-term complications, including autonomic neuropathy. Autonomic Nervous System (ANS) testing emerges as a vital tool in mitigating these risks, offering early detection and intervention opportunities.

 

Autonomic neuropathy, a common complication of diabetes, affects various bodily functions controlled by the autonomic nervous system, such as heart rate, blood pressure, and digestion. Timely identification of autonomic dysfunction is crucial for preventing severe complications, including cardiovascular disease and gastrointestinal disorders.

The American Diabetes Association recommends ANS testing as a standard of care for patients with Type 1 and Type 2 diabetes. By assessing the function of the autonomic nervous system, clinicians can detect early signs of neuropathy and implement preventive measures to preserve overall health.

 

The TM Flow machine facilitates ANS testing through non-invasive procedures that provide quantitative assessments of autonomic function. By distinguishing between early and late stages of autonomic neuropathy, the TM Flow enables healthcare providers to tailor treatment plans according to the individual needs of patients.

 

Incorporating ANS testing into diabetes management protocols enhances patient care by:

 

  • Identifying autonomic dysfunction early: Early detection allows for timely intervention, reducing the risk of complications and improving long-term outcomes.
  • Personalizing treatment plans: By understanding each patient’s autonomic status, clinicians can develop personalized care plans that address specific neuropathic symptoms and minimize the impact of diabetes-related complications.
  • Improving patient outcomes: Proactive management of autonomic neuropathy leads to better patient outcomes, including reduced hospitalizations, improved quality of life, and decreased healthcare costs.

In conclusion, ANS testing with the TM Flow machine is a valuable tool in diabetes management, offering early detection and intervention opportunities that enhance patient care. By integrating ANS testing into routine practice protocols, healthcare providers can mitigate the risks associated with autonomic neuropathy and improve the overall health outcomes of diabetic patients.

 

At Gateway Clinical, we are committed to revolutionizing patient care through innovative diagnostic solutions. As an authorized distributor for LD Technology, we proudly offer the TM Flow device, a state-of-the-art system designed to enhance the early detection of autonomic nervous system (ANS) and arterial dysfunction.

 

Our mission is to empower healthcare providers with advanced technology that improves patient outcomes and practice efficiency. The TM Flow device integrates seamlessly into clinical workflows, providing fast and accurate results that enable clinicians to make informed decisions about patient care in real-time.

 

With a focus on quality, reliability, and affordability, Gateway Clinical ensures that healthcare practices have access to cutting-edge diagnostic tools that deliver tangible benefits. Our team of dedicated professionals provides comprehensive support, including installation, training, and ongoing technical assistance, to ensure a seamless integration of the TM Flow device into your practice.

 

Moreover, Gateway Clinical offers 100% financing options through our finance partners, along with fast delivery and a lowest price guarantee. We are committed to providing value to your practice and helping you lower the cost of care for your patients.

 

By partnering with Gateway Clinical and adopting the TM Flow device, healthcare providers can optimize patient care, improve outcomes, and stay ahead in today’s competitive healthcare landscape. Experience the difference with Gateway Clinical and TM Flow – where innovation meets excellence in patient care.

 

Contact us today to learn more about how Gateway Clinical and the TM Flow device can transform your practice and elevate the standard of care for your patients.

RSS FEED

Go to Top